Karl Csaky

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies
    Karl Csaky
    Ophthalmic Unit, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    Am J Ophthalmol 148:647-56. 2009
  2. ncbi Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium
    Karl G Csaky
    Ophthalmic Unit, DCRI, Duke University Medical Center, Durham, NC 27710, USA
    Invest Ophthalmol Vis Sci 49:479-89. 2008
  3. ncbi Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina
    Hyuncheol Kim
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina 27705, USA
    Pharm Res 26:329-37. 2009
  4. ncbi Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat
    Jessica E Chan
    Duke University School of Medicine, Durham, NC, USA
    Exp Eye Res 90:501-6. 2010
  5. ncbi Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes
    Michael Cusick
    Division of Epidemiology and Clinical Research, National Eye Institute/NIH, Building 10, 10 Center Drive, Bethesda, MD 20892-1204, USA
    Am J Ophthalmol 139:1042-50. 2005
  6. ncbi Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related macular degeneration elicited by oxidative injury
    Nataly Strunnikova
    National Eye Institute, Bethesda, MD 20892-1857, USA
    Free Radic Biol Med 39:781-96. 2005
  7. ncbi Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity
    Maria E Marin-Castano
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, 1638 NW 10th Avenue, Miami, FL 33136, USA
    Invest Ophthalmol Vis Sci 46:3331-40. 2005
  8. ncbi Serum inflammatory markers in diabetic retinopathy
    Annal D Meleth
    Howard Hughes Medical Institute, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Invest Ophthalmol Vis Sci 46:4295-301. 2005
  9. ncbi Intravitreal injection of triamcinolone acetonide for immune recovery uveitis
    Maytinee Sirimaharaj
    Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, Australia
    Retina 26:578-80. 2006
  10. ncbi An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation
    Christine M Bojanowski
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Environ Mol Mutagen 47:594-602. 2006

Collaborators

  • Diana V Do
  • Hyuncheol Kim
  • F L Ferris
  • Chi Chao Chan
  • Scott W Cousins
  • E Chew
  • Sharon J Elliot
  • G Velez
  • Alan Marmorstein
  • J P SanGiovanni
  • Diego G Espinosa-Heidmann
  • Christine M Bojanowski
  • Jingsheng Tuo
  • Nataly Strunnikova
  • Michelle Thill
  • Annal D Meleth
  • Jessica E Chan
  • Eleut P Hernandez
  • Yingli Fu
  • Maytinee Sirimaharaj
  • Peng Yuan
  • George F Reed
  • Michael Cusick
  • Maria E Marin-Castano
  • Michael R Robinson
  • Hanna Rodriguez-Coleman
  • Jeremy D Wolfe
  • Alejandro Caicedo
  • Judit Baffi
  • Congxiao Zhang
  • Sunil K Srivastava
  • Tiffany A Pridgen
  • Nataliya Gordiyenko
  • Marc J Berna
  • Kristin Schmid
  • Darby J S Thompson
  • Natalya V Strunnikova
  • M Lourdes Ponce
  • Nam Sun Wang
  • Basil Donovan
  • Mark C Gillies
  • Baitang Ning
  • Meidong Zhu
  • DeFen Shen
  • W Richard Green
  • Florian Sutter
  • Gordon Byrnes
  • Sara Hilmer
  • Elvira Agrón
  • Rafael C Caruso
  • Kiran Arora
  • Eric Hoffman
  • Jessica Flippin
  • Maria A Reinoso
  • Michael Robinson
  • Yolanda Pina
  • Katherine Hall-Shimel
  • Diane Teichberg
  • Igal Gery
  • Brena C Smith
  • Luisa Gravlin
  • Connie Zhang
  • Sunil Srivastava
  • Kevin G Becker
  • Ivan J Suner
  • Dagoberto Monroy
  • Ivan Suner
  • William D Frazier

Detail Information

Publications29

  1. ncbi Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies
    Karl Csaky
    Ophthalmic Unit, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    Am J Ophthalmol 148:647-56. 2009
    ..To evaluate potential safety risks associated with nonspecific inhibition of vascular endothelial growth factor (VEGF)...
  2. ncbi Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium
    Karl G Csaky
    Ophthalmic Unit, DCRI, Duke University Medical Center, Durham, NC 27710, USA
    Invest Ophthalmol Vis Sci 49:479-89. 2008
  3. ncbi Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina
    Hyuncheol Kim
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina 27705, USA
    Pharm Res 26:329-37. 2009
    ..To investigate the movement of intravitreally injected human serum albumin nanoparticles (HSA-NP) with respect to nanoparticle surface charge and retinal injury...
  4. ncbi Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat
    Jessica E Chan
    Duke University School of Medicine, Durham, NC, USA
    Exp Eye Res 90:501-6. 2010
    ..Interestingly, the choroid does not appear to play a prominent role as clearance of episcleral NaFl was not affected by elimination of choroidal blood flow. Further work is needed to delineate the pathways of episcleral drug clearance...
  5. ncbi Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes
    Michael Cusick
    Division of Epidemiology and Clinical Research, National Eye Institute/NIH, Building 10, 10 Center Drive, Bethesda, MD 20892-1204, USA
    Am J Ophthalmol 139:1042-50. 2005
    ..Low scores on the NEI-VFQ-25 may reflect poor central visual fields and contrast sensitivity in addition to poor visual acuity...
  6. ncbi Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related macular degeneration elicited by oxidative injury
    Nataly Strunnikova
    National Eye Institute, Bethesda, MD 20892-1857, USA
    Free Radic Biol Med 39:781-96. 2005
    ..Despite the small number of patients in the study, specific biological and statistical differences in gene expression profiles between control and AMD patients were identified but only in the presence of an environmental stimulus...
  7. ncbi Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity
    Maria E Marin-Castano
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, 1638 NW 10th Avenue, Miami, FL 33136, USA
    Invest Ophthalmol Vis Sci 46:3331-40. 2005
    ....
  8. ncbi Serum inflammatory markers in diabetic retinopathy
    Annal D Meleth
    Howard Hughes Medical Institute, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Invest Ophthalmol Vis Sci 46:4295-301. 2005
    ..To evaluate the association of serum factors with the severity of diabetic retinopathy and to assess their presence in retinal tissue obtained at autopsy...
  9. ncbi Intravitreal injection of triamcinolone acetonide for immune recovery uveitis
    Maytinee Sirimaharaj
    Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, Australia
    Retina 26:578-80. 2006
  10. ncbi An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation
    Christine M Bojanowski
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Environ Mol Mutagen 47:594-602. 2006
    ..These results further confirm the association between ApoE112R and a decreased risk of AMD development. The underlying mechanisms may involve differential regulation of both CCL2 and VEGF by the ApoE isoforms...
  11. ncbi Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration
    Christine M Bojanowski
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Trans Am Ophthalmol Soc 103:37-44; discussion 44-5. 2005
    ..This study investigates the Hemicentin-1 (an extracellular matrix protein) Q5345R, hOgg1 (DNA repair gene) S326C, and E-selectin (an adhesion molecule) S149R SNPs in association with AMD...
  12. ncbi Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761
    Yingli Fu
    National Eye Institute, NIH, Bethesda, MD, USA
    Invest Ophthalmol Vis Sci 48:5184-90. 2007
    ....
  13. ncbi Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration
    Michelle Thill
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Invest Ophthalmol Vis Sci 49:2696-708. 2008
    ....
  14. ncbi Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization
    Diego G Espinosa-Heidmann
    Department of Ophthalmology, Bascom Palmer Eye Institute, William L McKnight Vision Research Center, The University of Miami School of Medicine, 1638 N W 10th Avenue, Miami, FL 33136, USA
    Exp Eye Res 80:369-78. 2005
    ..Knowledge of the cellular composition and origin might help understand the pathogenic mechanisms controlling CNV severity as well as indicate potential targets for therapeutic intervention...
  15. ncbi Indocyanine green enhanced retinal vessel laser closure in rats: histologic and immunohistochemical observations
    Jeremy D Wolfe
    National Eye Institute, National Institutes of Health, Building 10-10B11, 9000 Rockville Pike, Bethesda, MD 20892-1857, USA
    Exp Eye Res 79:631-8. 2004
    ..These results suggest that more durable feeder vessel closure rates may be achievable with either the use of accompanying anti-inflammatory therapies or with a less vascular damaging photoactivating dye...
  16. ncbi Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis
    Nataly Strunnikova
    National Eye Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-1859, USA
    Invest Ophthalmol Vis Sci 45:3767-77. 2004
    ....
  17. ncbi Age as an independent risk factor for severity of experimental choroidal neovascularization
    Diego G Espinosa-Heidmann
    Bascom Palmer Eye Institute, Department of Ophthalmology, The University of Miami School of Medicine, 1638 NW 10th Avenue, Miami, FL 33136, USA
    Invest Ophthalmol Vis Sci 43:1567-73. 2002
    ..Age-related systemic susceptibility factors, independent of local changes in the retina, may contribute to the greater severity of CNV in older than in younger individuals...
  18. ncbi Oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor
    Congxiao Zhang
    National Eye Institute, Building 10 Room 10N119, 9000 Rockville Pike, Bethesda, Maryland 20892 1857, USA
    J Cell Sci 116:1915-23. 2003
    ..These findings demonstrate the complex nature of cell death in primary cells of the retina and highlight the role of caspase-independent signals, growth factors and intracellular survival factors in programmed cell death pathways...
  19. ncbi In vivo gene transfer as a means to study the physiology and morphogenesis of the retinal pigment epithelium in the rat
    Alan D Marmorstein
    Department of Ophthalmic Research, Cole Eye Institute, i31, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Methods 30:277-85. 2003
    ..In addition, there are substantial savings with respect to time and money in comparison to standard transgenic approaches...
  20. ncbi Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization
    Diego G Espinosa-Heidmann
    Bascom Palmer Eye Institute, Department of Ophthalmology, The University of Miami School of Medicine, Miami, Florida, USA
    Invest Ophthalmol Vis Sci 44:3586-92. 2003
    ..96 +/- 7 pixels, P < 0.019). CONCLUSIONS: Macrophage depletion using CL(2)MDP-lip reduces size, cellularity, and vascularity of CNV. This observation supports the hypothesis that macrophages contribute to the severity of CNV lesions...
  21. ncbi The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study
    Emily Y Chew
    National Eye Institute/National Institutes of Health, Division of Epidemiology and Clinical Research, Bethesda, Maryland 20892-2510, USA
    Ophthalmology 110:1683-9. 2003
    ..The need for laser scatter photocoagulation with long-term follow-up seems to be high...
  22. ncbi Identification of well-defined intrachoroidal neovascularization by high-speed indocyanine green angiography
    Sunil K Srivastava
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892-1857, USA
    Retina 23:712-4. 2003
  23. ncbi Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization
    Diego G Espinosa-Heidmann
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida 33136, USA
    Invest Ophthalmol Vis Sci 44:4914-9. 2003
    ..CONCLUSIONS: This study is the first to demonstrate that bone marrow-derived progenitor cells are a source of endothelial and smooth musclelike cells in CNV...
  24. ncbi Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor
    Karl G Csaky
    National Institutes of Health, National Eye Institute, Building 10 10B11, 9000 Rockville Pike, Bethesda, MD 20892 1857, USA
    Exp Eye Res 78:1107-16. 2004
    ....
  25. ncbi The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration
    Jingsheng Tuo
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    FASEB J 18:1297-9. 2004
    ..Our data suggest that a decrease, caused by sequence variation and/or lower CX3CR1 expression, in CX3CR1-induced cellular activities could contribute to AMD development...
  26. ncbi Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?
    Scott W Cousins
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Fla 33136, USA
    Arch Ophthalmol 122:1013-8. 2004
    ....
  27. ncbi Intravitreal injection of triamcinolone for diffuse macular edema
    Hanna Rodriguez-Coleman
    Arch Ophthalmol 122:1085-6; author reply 1086-8. 2004
  28. ncbi Fluorescein angiographic findings in primary intraocular lymphoma
    Gisela Velez
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Retina 22:37-43. 2002
    ..A noninvasive ancillary test such as fluorescein angiography could be helpful in raising the level of suspicion in the diagnosis of this disease...